An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device
CompletedOBSERVATIONAL
Enrollment
230
Participants
Timeline
Start Date
April 30, 2012
Primary Completion Date
October 31, 2012
Conditions
Relapsing Multiple Sclerosis
Trial Locations (1)
Unknown
Please contact the, Merck KGaA Communication Center For Recruiting Locations
All Listed Sponsors
collaborator
Merck Serono Limited, UK
INDUSTRY
lead
Merck KGaA, Darmstadt, Germany
INDUSTRY
NCT01601080 - An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device | Biotech Hunter | Biotech Hunter